The ideal candidate will possess a comprehensive understanding of CNS conditions and a proven track record in specialty sales. Strong interpersonal and communication skills are essential for building relationships with healthcare professionals. Experience in managing complex accounts and a bachelor's degree in a relevant field are preferred.
About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical company, as we revolutionize the treatment landscape for central nervous system (CNS) disorders. Our mission focuses on delivering groundbreaking scientific advancements that address critical care gaps, leading to the development of unique products with innovative mechanisms of action. Our esteemed neuroscience portfolio features FDA-approved therapies for major depressive disorder, excessive daytime sleepiness linked to narcolepsy and obstructive sleep apnea, as well as migraine treatments. We are also engaged in multiple late-stage development programs targeting a wide array of serious neurological and psychiatric conditions, affecting over 150 million individuals across the United States. Together, we are dedicated to overcoming some of the most significant challenges facing brain health, enabling patients and their families to thrive. For more details, visit us at www.axsome.com and connect with us on LinkedIn.
About Axsome Therapeutics
Axsome Therapeutics is at the forefront of biopharmaceutical innovation, focusing on CNS disorders. Our commitment to developing impactful treatments and improving patient outcomes positions us as leaders in the neuroscience sector.
This job posting is no longer active and is not accepting applications.
The ideal candidate will possess a comprehensive understanding of CNS conditions and a proven track record in specialty sales. Strong interpersonal and communication skills are essential for building relationships with healthcare professionals. Experience in managing complex accounts and a bachelor's degree in a relevant field are preferred.
About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical company, as we revolutionize the treatment landscape for central nervous system (CNS) disorders. Our mission focuses on delivering groundbreaking scientific advancements that address critical care gaps, leading to the development of unique products with innovative mechanisms of action. Our esteemed neuroscience portfolio features FDA-approved therapies for major depressive disorder, excessive daytime sleepiness linked to narcolepsy and obstructive sleep apnea, as well as migraine treatments. We are also engaged in multiple late-stage development programs targeting a wide array of serious neurological and psychiatric conditions, affecting over 150 million individuals across the United States. Together, we are dedicated to overcoming some of the most significant challenges facing brain health, enabling patients and their families to thrive. For more details, visit us at www.axsome.com and connect with us on LinkedIn.
About Axsome Therapeutics
Axsome Therapeutics is at the forefront of biopharmaceutical innovation, focusing on CNS disorders. Our commitment to developing impactful treatments and improving patient outcomes positions us as leaders in the neuroscience sector.